Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
05/2005
05/26/2005WO2005047486A2 Biological production of tetradehydrolycopene
05/26/2005WO2005047485A2 Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast
05/26/2005WO2005047480A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
05/26/2005WO2005047479A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
05/26/2005WO2005047473A2 Single vector dual gene therapy for pulmonary hypertension
05/26/2005WO2005047469A2 PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
05/26/2005WO2005047321A2 Polynucleotides for inhibition of polypeptide expression and methods of use
05/26/2005WO2005047320A2 Equine p-selection glycoprotein ligand-1 and uses thereof
05/26/2005WO2005047314A2 Fgf-beta binding and supported peptides
05/26/2005WO2005047305A2 Cellular membrane protein assay
05/26/2005WO2005047302A1 Expression in filamentous fungi of protease inhibitors and variants thereof
05/26/2005WO2005046721A2 Compositions for reducing bacterial carriage and cns invasion and methods of using same
05/26/2005WO2005046710A2 Tgf-beta binding and supported peptides
05/26/2005WO2005046709A2 Tgf - beta binding and supported peptides
05/26/2005WO2005046314A2 Tomatoes having altered acid invertase activity due to non-transgenic alterations in acid invertase genes
05/26/2005WO2005046309A2 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene
05/26/2005WO2005012516A3 Maize cellulose synthases and uses thereof
05/26/2005WO2004092356A3 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules
05/26/2005WO2004073604A3 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
05/26/2005WO2004058177A3 Crystals and structures of spleen tyrosine kinase sykkd
05/26/2005WO2004055176A3 Trans-sialidases obtained from trypanosoma congolense
05/26/2005WO2004042068A3 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
05/26/2005WO2004031376A3 Sesquiterpene synthases and methods of use
05/26/2005WO2003053341A3 Antisense modulation of ship-1 expression
05/26/2005US20050114921 For producing green note compounds comprising reacting fatty acid hydroperoxide in the presence of isolated recombinant protein
05/26/2005US20050114035 Method for binding site identification
05/26/2005US20050113565 Pegylated factor VII glycoforms
05/26/2005US20050113562 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof
05/26/2005US20050113415 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders
05/26/2005US20050113329 Contacing cell/body fluid with antibody which binds human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide; for inhibiting tumor growth; gene expression inhibition; immunization
05/26/2005US20050113327 Administering by direct infusion to a colon cancer or melanoma native RNase B1 isolated from Aspergillus niger; reducing tumor number or size of colon cancer or melanoma
05/26/2005US20050113303 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity
05/26/2005US20050113284 Drug for regenerating tissue and vessel and method therefor
05/26/2005US20050113273 Alkaline protease from bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease
05/26/2005US20050112755 Ultrafiltration charging membrane
05/26/2005US20050112751 Novel class of therapeutic protein based molecules
05/26/2005US20050112750 Chitin degradative systems
05/26/2005US20050112748 Low molecular weight gtpase rhot
05/26/2005US20050112747 Rat secreted embryonic alkaline phosphatase
05/26/2005US20050112746 Protein embedding in three-dimensional structure; detecting binding with ligand; computer analysis
05/26/2005US20050112745 Transferases
05/26/2005US20050112744 Glucose dehydrogenase fusion proteins and their use in expression systems
05/26/2005US20050112743 Method of analyzing enzyme compositions with lipolytic, proteolytic and amylolytic activity
05/26/2005US20050112742 Heat resistance; stable pH; Thermus culture product
05/26/2005US20050112734 Forming chemical intermediate, such as 2-ketogluconate, for ascorbic acid
05/26/2005US20050112733 Process for the preparation of L-amino acids with amplification of the zwf gene
05/26/2005US20050112732 Alleles of the glucokinase gene coryneform bacteria
05/26/2005US20050112731 Mutant serine acetyltransferase
05/26/2005US20050112730 Nucleotide sequences which code for the opcA gene
05/26/2005US20050112729 Recombinant DNA having hydantoinase gene and carbamylase gene and process for producing amino acid
05/26/2005US20050112728 Polynucleotide coding enzyme catalyst for biosynthesis; gene expression; forming antibiotic
05/26/2005US20050112727 For producing a glycosaminoglycan
05/26/2005US20050112726 Biosynthetic gene cluster for leptomycins
05/26/2005US20050112723 Mammalian cell lines specifically deficient in O-linked glycosylation
05/26/2005US20050112720 Soluble complexes of amylod beta peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
05/26/2005US20050112719 Product and process for transformation of thraustochytriales microorganisms
05/26/2005US20050112714 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
05/26/2005US20050112713 Methods of using Fab I and compounds modulating Fab I activity
05/26/2005US20050112709 Histone h3methyltransferase polypeptide
05/26/2005US20050112705 Detecting cancer perticularly of prostate gland
05/26/2005US20050112664 Nucleotide sequences coding for the citA gene
05/26/2005US20050112644 Thermostable hydrolase
05/26/2005US20050112643 Polypeptide related to the kinase family; cell mtosis; detection binding pattern
05/26/2005US20050112641 Protein mixture which confers antibiotic resistance
05/26/2005US20050112637 Mutant DNA polymerases and uses thereof
05/26/2005US20050112631 Using polymerase amplification to propagate target Dna
05/26/2005US20050112612 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
05/26/2005US20050112580 Bacillus stearothermophilus tau, delta, and delta prime polymerase subunits and use thereof
05/26/2005US20050112579 Modulate protease activity; tumor markers; catalyst
05/26/2005US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility
05/26/2005US20050112571 Dna molecules conferring tolerance to herbicidal compounds
05/26/2005US20050112565 Proteases
05/26/2005US20050112237 food additive with a PS4 variant polypeptide derivable from a parent polypeptide having non-maltogenic exoamylase activity; baked goods; glucan 1,4-alpha-maltotetrahydrolase activity
05/26/2005US20050112134 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
05/26/2005US20050112118 Compositions and methods for treating inflammatory disorders
05/26/2005US20050112101 Methods of treating restenosis
05/26/2005CA2548080A1 Porcine isogloboside 3 synthase protein, cdna, genomic organization, and regulatory region
05/26/2005CA2546243A1 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses
05/26/2005CA2545325A1 Compositions for reducing bacterial carriage and cns invasion and methods of using same
05/26/2005CA2545053A1 Expression in filamentous fungi of protease inhibitors and variants thereof
05/26/2005CA2544820A1 Bacterial expression of protease inhibitors and variants thereof
05/26/2005CA2544688A1 Cellular membrane protein assay
05/26/2005CA2544618A1 Glycin decarboxylase complex as a herbicidal target
05/26/2005CA2544507A1 Optimised micro-organism strains for nadph-consuming biosynthetic pathways
05/26/2005CA2542574A1 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast
05/26/2005CA2542564A1 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast
05/26/2005CA2541216A1 .delta.12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast
05/25/2005EP1533376A1 Novel aldolases and process for producing substituted alpha-keto acid
05/25/2005EP1533372A1 Human phospholipase C-Alpha and DNA sequence encoding the same
05/25/2005EP1533318A1 Prodrugs of thrombin inhibitors
05/25/2005EP1533020A1 Purification and concentration synthetic biological molecules
05/25/2005EP1532861A1 Cathepsin-associaged genetically modified nonhuman mammal
05/25/2005EP1532439A2 Unique recognition sequences and methods of use thereof in protein analysis
05/25/2005EP1532276A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases
05/25/2005EP1532271A2 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
05/25/2005EP1532266A2 Method for producing ketocarotinoids in plant fruit
05/25/2005EP1532265A2 Method for producing ketocarotinoids in genetically modified organisms
05/25/2005EP1532264A2 Method for the production of ketocarotinoids in flower petals on plants
05/25/2005EP1532263A2 Method for hydrolysing carotenoids esters
05/25/2005EP1532256A1 Method for the production of $g(b)-carotinoids
1 ... 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 ... 1416